StockData

Gevo vs Green Plains

GEVO and GPRE side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GEVO and GPRE compare

Green Plains is the larger company, worth 2.1 times as much as Gevo ($934M against $452M).

Gevo grew revenue faster over the last twelve months (80.1% versus −19.1% for Green Plains).

Green Plains keeps more of each dollar of sales as profit, with a net margin of 10.9% compared with −83.7% at Gevo.

Green Plains scores higher on the StockData Score (13 against 8 for Gevo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGEVOGPRE
Size and price
Market cap$452M$934M
Share price$1.83$13.32
Change, 1 year−13.7%36.3%
Change, 5 years−71.0%−67.0%
Beta (5Y)1.730.85
Employees151642
StockData Score
Total score813 (better)
Valuation score25 (better)
Growth score4 (better)1
Performance score14 (better)
Health score13 (better)
Dividend score00
Valuation
P/E–5.4×
P/S2.1×0.5× (better)
P/B1.5×1.0× (better)
EV/EBITDA–4.8×
P/FCF–11.6×
FCF yield−6.8%8.6% (better)
Fair value$2.94$68.08
Margin of safety37.7%80.4% (better)
Growth
Revenue growth (TTM)80.1% (better)−19.1%
Revenue growth, 5Y average96.1% (better)1.7%
Profitability
Gross margin51.2% (better)19.7%
Operating margin−68.2%9.3% (better)
Net margin−83.7%10.9% (better)
FCF margin−14.2%4.4% (better)
Return on equity−47.5%22.9% (better)
Return on invested capital−24.5%15.4% (better)
Financial health
Debt / equity0.560.50 (better)
Net debt / EBITDA–1.21
Interest coverage−7.1×5.0× (better)
Current ratio2.042.31 (better)
Altman Z-score−1.812.17 (better)
Piotroski F-score45 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions37.2%111%
Held by insiders4.8%18.1%
Insider net buying, 12 months−$2.5M$101K (better)
Short interest, % of float10.6%22.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.